News
Tesamorelin for Sleep-Disordered Breathing Link...
Late-night GLP-1 dosing can worsen sleep-disordered breathing. Tesamorelin, a GHRH analog, may reduce visceral fat and improve slow-wave sleep
Tesamorelin for Sleep-Disordered Breathing Link...
Late-night GLP-1 dosing can worsen sleep-disordered breathing. Tesamorelin, a GHRH analog, may reduce visceral fat and improve slow-wave sleep
Can DSIP Counteract Late-Night Peptide Circadia...
Late-night Tesamorelin injections can delay sleep onset and fragment deep sleep. DSIP, a peptide studied since 1977, may blunt cortisol spikes and pull
Can DSIP Counteract Late-Night Peptide Circadia...
Late-night Tesamorelin injections can delay sleep onset and fragment deep sleep. DSIP, a peptide studied since 1977, may blunt cortisol spikes and pull
Tesamorelin and DSIP for Night Shift Circadian ...
Night shift work disrupts sleep architecture. Tesamorelin and DSIP appear in Russian longevity literature as potential tools, but combination data are
Tesamorelin and DSIP for Night Shift Circadian ...
Night shift work disrupts sleep architecture. Tesamorelin and DSIP appear in Russian longevity literature as potential tools, but combination data are
Can DSIP Mitigate Sleep Disruption From GLP-1 I...
GLP-1 agonists can fragment sleep, but delta sleep-inducing peptide (DSIP) may restore normal architecture. Russian research spanning decades
Can DSIP Mitigate Sleep Disruption From GLP-1 I...
GLP-1 agonists can fragment sleep, but delta sleep-inducing peptide (DSIP) may restore normal architecture. Russian research spanning decades
Tesamorelin and DSIP for Circadian Repair Durin...
Sleep disruption has emerged as one of the more stubborn companions of GLP-1 receptor agonist therapy. Patients losing weight on semaglutide or
Tesamorelin and DSIP for Circadian Repair Durin...
Sleep disruption has emerged as one of the more stubborn companions of GLP-1 receptor agonist therapy. Patients losing weight on semaglutide or
How the FDA Panel Vote Could Expand Pharmacy Ac...
The FDA panel vote on tesamorelin could indirectly expand pharmacy access to DSIP for shift workers with circadian disruption. Russian research
How the FDA Panel Vote Could Expand Pharmacy Ac...
The FDA panel vote on tesamorelin could indirectly expand pharmacy access to DSIP for shift workers with circadian disruption. Russian research